In a similar study by Mieog et al. [74], the clinical translation of a novel NIR fluorescence imaging system and the optimal ratio of ICG to the human serum albumin (HSA) dose for mapping of SLN in breast cancer was described. The gene discussed is ALB; the disease is breast cancer.